Erlotinib Monotherapy for the Maintenance Treatment of Non-Small Cell Lung Cancer after Previous Platinum-Containing Chemotherapy: A NICE Single Technology Appraisal

Author： Dickson Rumona  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.29, Iss.12, 2011-12, pp. : 1051-1062

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intercalation of Erlotinib and Pemetrexed in the Treatment of Non-Small Cell Lung Cancer

By  

Current Drug Targets, Vol. 11, Iss. 1, 2010-01 ,pp. : 85-94

Bentham Science Publishers

Access to resources Recommend Favorite

Safety profile of platinum-based chemotherapy in the treatment of advanced non-small cell lung cancer in elderly patients

By Rossi Antonio   Maione Paolo   Gridelli Cesare  

Expert Opinion on Drug Safety, Vol. 4, Iss. 6, 2005-11 ,pp. : 1051-1067

Informa Healthcare

Access to resources Recommend Favorite

Erlotinib in non-small cell lung cancer: a review

By Blackhall Fiona H   Rehman Shazza   Thatcher Nicholas  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 6, 2005-06 ,pp. : 995-1002

Informa Healthcare

Access to resources Recommend Favorite

Erlotinib Resistance is Altered after Gemcitabine Chemotherapy for Recurrent Non-Small-Cell Lung Cancer

By Wang Yongzheng  

Clinical Drug Investigation, Vol. 31, Iss. 4, 2011-04 ,pp. : 279-283

Adis International

Access to resources Recommend Favorite

Novel combination chemotherapy in the treatment of non-small cell lung cancer

By Sekine I.   Saijo N.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 6, 2000-09 ,pp. : 1131-1161

Informa Healthcare

Access to resources Recommend Favorite